Related Articles
Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors
AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors
Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice
Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression
Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab